Consequences of the COVID-19 Outbreak Lockdown on Non-Viral Infectious Agents as Reported by a Laboratory-Based Surveillance System at the IHU Méditerranée Infection, Marseille, France.
COVID-19
clinical microbiology laboratory
diversity
epidemiology
lockdown
syndromic surveillance
wild
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 Jul 2021
21 Jul 2021
Historique:
received:
27
04
2021
revised:
28
05
2021
accepted:
14
06
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
8
8
2021
Statut:
epublish
Résumé
The objective of this paper is to describe the surveillance system MIDaS and to show how this system has been used for evaluating the consequences of the French COVID-19 lockdown on the bacterial mix of AP-HM and the antibiotic resistance. MIDas is a kind of surveillance activity hub, allowing the automatic construction of surveillance control boards. We investigated the diversity and resistance of bacterial agents from respiratory, blood, and urine samples during the lockdown period (from week 12 to 35 of 2020), using the same period of years from 2017 to 2019 as control. Taking into account the drop in patient recruitment, several species have exhibited significant changes in their relative abundance (either increasing or decreasing) with changes up to 9%. The changes were more important for respiratory and urine samples than for blood samples. The relative abundance in respiratory samples for the whole studied period was higher during the lockdown. A significant increase in the percentage of wild phenotypes during the lockdown was observed for several species. The use of the MIDaS syndromic collection and surveillance system made it possible to efficiently detect, analyze, and follow changes of the microbiological population as during the lockdown period.
Identifiants
pubmed: 34361994
pii: jcm10153210
doi: 10.3390/jcm10153210
pmc: PMC8348674
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Agence Nationale de la Recherche
ID : Méditerranée-Infection 10-IAHU-03
Organisme : European Regional Development Fund
ID : FEDER PRIMMI
Références
Nat Microbiol. 2016 Nov 07;1:16203
pubmed: 27819657
Ann Intensive Care. 2020 Sep 7;10(1):119
pubmed: 32894364
Lancet Public Health. 2020 May;5(5):e255
pubmed: 32275857
Euro Surveill. 2020 Jul;25(30):
pubmed: 32734857
Swiss J Econ Stat. 2020;156(1):11
pubmed: 32874959
Trop Dis Travel Med Vaccines. 2020 Aug 28;6:16
pubmed: 32868984
Curr Opin Crit Care. 2015 Oct;21(5):421-9
pubmed: 26165502
Emerg Infect Dis. 2015 Aug;21(8):1302-10
pubmed: 26196165
J Infect. 2017 Jul;75(1):59-67
pubmed: 28366686
Front Microbiol. 2020 Aug 13;11:1931
pubmed: 32903575
Stat Med. 1989 Mar;8(3):323-9; discussion 331-2
pubmed: 2540519
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):625
pubmed: 32553138
Euro Surveill. 2020 Apr;25(15):
pubmed: 32317053
PLoS One. 2015 Dec 14;10(12):e0144178
pubmed: 26658293
Emerg Med Australas. 2018 Jun;30(3):431-433
pubmed: 29484824
Br J Haematol. 2020 Jun;189(6):e224-e227
pubmed: 32369622
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037
Pathog Dis. 2013 Nov;69(2):114-26
pubmed: 23913525
J Korean Med Sci. 2019 Sep 02;34(34):e228
pubmed: 31456383